SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+/HER2− ADVANCED OR METASTATIC BREAST CANCER . Vietnam Journal of Community Medicine, v. 67, n. 10, 4 Nov.2026.